Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Glycerol Monooleate 40 offers a unique profile in the pharmaceutical ingredient world. As a mixed mono- and diglyceride, it finds its foundation in glycerin and oleic acid, both sourced from plant-derived oils. This material stands out with a chemical formula of C21H40O4 and a molecular weight around 356.54 g/mol. End-users in the pharmaceutical sector often choose this grade for its defined purity and compliance with stringent quality standards, including British Pharmacopoeia (BP), European Pharmacopoeia (EP), and United States Pharmacopeia (USP). Its transparent specifications help manufacturers trace quality and chemical identity through documentation including HS Code 3824, giving a point of reference for international trade, regulatory filings, and import-export controls.
In handling Glycerol Monooleate 40, physical characteristics play a practical role in application and processing. The product ranges in appearance from off-white flakes and soft, waxy solids to free-flowing powders and glossy pearls, even extending to viscous, amber-hued liquids if temperature allows. This substance retains a mild, fatty scent. At room temperature, its density measures close to 0.97 to 0.98 g/cm³, which signals good dispersibility in blends or as a system stabilizer. Melting between 33°C and 38°C, it transitions softly — a property useful for formulators who require easy integration without harsh thermal conditions. Water solubility remains limited, but strong solubility surfaces in ethanol, acetone, and similar solvents. Chemists value these traits for the solvent-extraction and blending phases. In particulate or pearl form, the low dust potential minimizes product loss and makes for cleaner handling, which matters during batch manufacturing. These different forms bring operational flexibility, directly impacting process choices or the end application.
With its monoester baseline, Glycerol Monooleate provides both hydrophilic and lipophilic regions in each molecule, classifying it as a non-ionic emulsifier. This structure allows for both oil-in-water and water-in-oil emulsion creation, a property central in creams, ointments, and topical formulations. Its hydrophilic-lipophilic balance (HLB) typically registers between 3.5 and 4, fitting emulsions that favor oil phases, yet harmonious with additives that shift the balance toward water compatibility. As a raw material, it brings in a high monoester content, making it reliable for regulatory submissions that demand consistency from lot to lot. Understanding its molecular profile goes beyond technical paperwork; for R&D teams, this breaks the barrier between therapeutic ideas and scalable production.
Each batch of Glycerol Monooleate 40 BP EP USP Pharma Grade must adhere to clear-cut metrics. Assay values for monooleates usually reach a minimum of 40%, guaranteeing the headline component remains prominent. Acid values span from 5 to 10 mg KOH/g, indicating low free acid, which keeps degradation at bay and supports long shelf-life. Saponification values land near 160 to 185 mg KOH/g, confirming the presence of esters within specification. Residual solvents and heavy metals are strictly limited per pharmacopeial rules, an assurance for sensitive drug uses. Peroxide values stay low, suppressing unwanted oxidation reactions. Each of these numbers reflects real-world outcomes — a reliable batch offers peace of mind for analysts, production managers, and patients alike.
The pharmaceutical sector reaches for Glycerol Monooleate 40 to solve practical formulation problems. As an emulsifier, it stabilizes both topical and oral drug carriers, improving patient experience by preventing separation or gritty mouthfeel. In suppositories or creams, it controls moisture migration, which enhances both user comfort and product shelf-life. Its function as a solubilizing and wetting agent increases bioavailability of fat-soluble actives, helping deliver consistent therapeutic levels. In my experience supporting formulation labs, the animal-free, non-GMO sourcing of raw materials often sways decision-makers, especially in regulated environments where consumer and regulatory scrutiny co-exist. This grade's pharma compliance means its presence in end products stands up to audits, import checks, and healthcare traceability demands.
Bulk users encounter Glycerol Monooleate 40 either in paper or plastic-lined bags for solid forms, and steel or HDPE drums for liquids and pastes. Storage rooms benefit from stable temperatures under 30°C and protection from light and moisture to preserve color and acidity. As a low-dust, non-hygroscopic raw material, workplace exposure risks remain low for trained personnel, though personal protective gear should always remain standard practice. I’ve seen manufacturers simplify compliance by integrating closed transfer and automated batching, reducing exposure and contamination events. Documentation provided with each batch — COA, TDS, MSDS — answers regulators and customers before they ask, building both workflow efficiency and trust.
Glycerol Monooleate 40 BP EP USP Pharma Grade comes with a strong safety profile. Labeled as non-hazardous, non-flammable, and low-toxicity, it aligns with chemical regulations across the globe. Handling instructions remain straightforward: wear gloves, avoid prolonged skin contact, and practice standard hygiene. Spills tend not to spread toxicity but can create slip hazards due to their oily nature. Waste management focuses on basic containment and recycling protocols consistent with GMP and Good Laboratory Practice (GLP). Down the supply chain, biodegradable characteristics and renewable sourcing of glycerin and oleic acid offer a step toward sustainability. This environmental bonus holds weight as pharmaceutical companies answer to public and policy pressure for greener operations.
Current trends point to rising demand due to clean label movement and expanded applications in new dosage forms. Companies switching from synthetic to plant-based excipients find Glycerol Monooleate 40 a comfortable fit. Emerging markets now require higher transparency; thus, documentation and traceability take on more significance for global suppliers. Ongoing research into new drug delivery systems may unlock further uses, as nanoemulsions and self-microemulsifying drug delivery systems (SMEDDS) seek non-ionic surfactants that comply with all three BP, EP, and USP standards. Direct cooperation between excipient manufacturers and formulation scientists enables rapid troubleshooting, and in my experience, the strongest partnerships enable seamless transitions from lab to full-scale production.
Chengguan District, Lanzhou, Gansu, China
